Lenalid Capsule (Lenalidomide) – Multiple Myeloma & Lepra Reaction Treatment

Lenalid (Lenalidomide) (generic equivalent to Revlimid) is a prescription targeted oncology medication for the treatment of multiple myeloma and lepra reaction (erythema nodosum leprosum). As a targeted therapy, it works at a molecular level to slow cancer cell proliferation while sparing healthy tissue.
Composition: Lenalidomide (5mg / 10mg / 15mg / 25mg)
Manufacturer: Natco Pharma Ltd
Prescription-only oncology medication. Use only under the direct supervision of a licensed oncologist. Regular blood tests and monitoring are mandatory throughout treatment.